XenTech
Created in 2006
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
123 1,573Activities
Technologies
Entity types
Location
4 Rue Pierre Fontaine, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 11-50
Estimated: 33
SIREN
489625616Engaged corporates
2
0 2Added in Motherbase
5 years ago
biotech Value proposition
Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years.
XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...)
In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.
patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assaysOriginal language
Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years.
XenTech is Contract Research Organization (CRO) dedicated to cancer biomarkers and translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates.
In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify biomarkers and therapeutic targets.
Home - Xentech
https://www.xentech.eu/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 7 Dec 2016 | | |
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Event 1 Apr 2019 | | |